drugset / Trial / NCT03977493
IncobotulinumtoxinA (Xeomin) to Treat Focal Hand Dystonia
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is a multicenter, double-blind, randomized placebo controlled, parallel group, superiority trial in order to test the superiority of intramuscular injections of IncobotulinumtoxinA against placebo using a 1:1 allocation ratio.
Timeline
- Start
- 2018-02-21
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 2.5 iu | Intramuscular |
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 40 iu | Intramuscular |